TY - JOUR
T1 - Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)
AU - Bellos, E
AU - Santillo, D
AU - Vantourout, P
AU - Jackson, JR
AU - Duret, A
AU - Hearn, H
AU - Seeleuthner, Y
AU - Talouarn, E
AU - Hodeib, S
AU - Patel, H
AU - Powell, O
AU - Yeoh, S
AU - Mustafa, S
AU - Habgood-Coote, D
AU - Nichols, S
AU - Estramiana Elorrieta, L
AU - D'Souza, G
AU - Wright, VJ
AU - et al., null
PY - 2024/12/2
Y1 - 2024/12/2
N2 - Multisystem inflammatory syndrome in children (MIS-C) is a rare condition following SARS-CoV-2 infection associated with intestinal manifestations. Genetic predisposition, including inborn errors of the OAS-RNAseL pathway, has been reported. We sequenced 154 MIS-C patients and utilized a novel statistical framework of gene burden analysis, "burdenMC," which identified an enrichment for rare predicted-deleterious variants in BTNL8 (OR = 4.2, 95% CI: 3.5-5.3, P < 10-6). BTNL8 encodes an intestinal epithelial regulator of Vγ4+γδ T cells implicated in regulating gut homeostasis. Enrichment was exclusive to MIS-C, being absent in patients with COVID-19 or bacterial disease. Using an available functional test for BTNL8, rare variants from a larger cohort of MIS-C patients (n = 835) were tested which identified eight variants in 18 patients (2.2%) with impaired engagement of Vγ4+γδ T cells. Most of these variants were in the B30.2 domain of BTNL8 implicated in sensing epithelial cell status. These findings were associated with altered intestinal permeability, suggesting a possible link between disrupted gut homeostasis and MIS-C-associated enteropathy triggered by SARS-CoV-2.
AB - Multisystem inflammatory syndrome in children (MIS-C) is a rare condition following SARS-CoV-2 infection associated with intestinal manifestations. Genetic predisposition, including inborn errors of the OAS-RNAseL pathway, has been reported. We sequenced 154 MIS-C patients and utilized a novel statistical framework of gene burden analysis, "burdenMC," which identified an enrichment for rare predicted-deleterious variants in BTNL8 (OR = 4.2, 95% CI: 3.5-5.3, P < 10-6). BTNL8 encodes an intestinal epithelial regulator of Vγ4+γδ T cells implicated in regulating gut homeostasis. Enrichment was exclusive to MIS-C, being absent in patients with COVID-19 or bacterial disease. Using an available functional test for BTNL8, rare variants from a larger cohort of MIS-C patients (n = 835) were tested which identified eight variants in 18 patients (2.2%) with impaired engagement of Vγ4+γδ T cells. Most of these variants were in the B30.2 domain of BTNL8 implicated in sensing epithelial cell status. These findings were associated with altered intestinal permeability, suggesting a possible link between disrupted gut homeostasis and MIS-C-associated enteropathy triggered by SARS-CoV-2.
UR - http://www.scopus.com/inward/record.url?scp=85210466949&partnerID=8YFLogxK
U2 - 10.1084/jem.20240699
DO - 10.1084/jem.20240699
M3 - Article
C2 - 39576310
VL - 221
JO - Journal of Experimental Medicine (JEM)
JF - Journal of Experimental Medicine (JEM)
IS - 12
M1 - e920240699
ER -